# A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy

> **NCT00235443** · PHASE2,PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 451 (actual)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** lacosamide

## Key facts

- **NCT ID:** NCT00235443
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 451 (ACTUAL)
- **Last updated:** 2018-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235443, "A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00235443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*